New Research Poster Presentation 2.25
An Open-Label Pharmacokinetics and Safety Study of Vortioxetine in Pediatric Patients
Thursday, October 29, 2015 10:00 AM
Robert L. Findling, MD, MBA, The Johns Hopkins University, Baltimore, MD
Adelaide S. Robb, MD, Children's National Medical Center, Washington, DC
Melissa P. DelBello, MD, MS, University of Cincinnati College of Medicine, Cincinnati, OH
Michael Huss, MD, Department of Child and Adolescent Psychiatry, University of Medicine, Mainz, Germany
Nora McNamara, MD, Department of Psychiatry, University Hospitals Case Medical Center, Cleveland, OH
Elias Sarkis, MD, Sarkis Family Psychiatry, Gainesville, FL
Russell Scheffer, MD, psychiatry, University of Kansas School of Medicine-Wichita, Wichta, KS
Lis Poulsen, H. Lundbeck A/S, 2500, Denmark
Grace Chen, PhD, Clinical Pharmacology, Takeda Development Center Americas, Inc., Deerfield, IL
Johan Areberg, PhD, Quantitavie Pharmacology, H. Lundbeck A/S, Valby, Denmark
Philippe Auby, MD, GCR Paediatric Neuro-Psychiatry, Lundbeck SAS, Cedex, France
